Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma

By You Heon   Kim Young   Im Soo   Suh-Kim Haeyoung   Paek Sun   Park Sung-Hye   Kim Dong   Jung Hee-Won  

Journal of Neuro-Oncology, Vol. 74, Iss. 1, 2005-08 ,pp. : 1-8

Springer Publishing Company

Access to resources Recommend Favorite

Combination of rituximab and mammalian target of rapamycin inhibitor everolimus (RAD001) in diffuse large B-cell lymphoma

By Xu Zi-Zhen   Wang Wen-Fang   Fu Wan-Bin   Wang Ai-Hua   Liu Zhi-Yin   Chen Li-Yun   Guo Pei   Li Jun-Min  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1151-1157

Informa Healthcare

Access to resources Recommend Favorite

Testicular cancer and the tuberous sclerosis complex

By Tandstad Torgrim   Indrebø Gunnar  

Acta Oncologica, Vol. 51, Iss. 2, 2012-02 ,pp. : 262-265

Informa Healthcare

Access to resources Recommend Favorite

The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study

By Macaskill E.  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 725-734

Springer Publishing Company

Access to resources Recommend Favorite

The mTOR pathway inhibitor RAD001 (everolimus) is highly efficacious in tamoxifen-sensitive and -resistant breast cancer xenografts

By Behrens Diana   Lykkesfeldt Anne   Fichtner Iduna  

Targeted Oncology, Vol. 2, Iss. 3, 2007-07 ,pp. : 135-144

Springer Publishing Company

Access to resources Recommend Favorite